Bausch + Lomb completes Technolas Perfect Vision buyout

Eye health company Bausch + Lomb has officially acquired ophthalmology laser developer and maker Technolas Perfect Vision.

Eye health company Bausch + Lomb (Rochester, NY) has officially acquired ophthalmology laser developer and maker Technolas Perfect Vision (Munich, Germany). The new entity will be known as Bausch + Lomb Technolas, which will continue to develop and commercialize surgical laser technology in the ophthalmic field.

Bausch + Lomb originally announced its intent to purchase all outstanding and unowned shares of Technolas Perfect Vision in November 2012. Technolas Perfect Vision was established in 2009 through a joint venture between Bausch + Lomb and 20/10 PERFECT VISION AG to develop and sell advanced refractive and cataract technologies. Financial details of the acquisition are not being disclosed.

The Technolas Perfect Vision team will become part of Bausch + Lomb’s Surgical business, and its femtosecond and excimer laser platforms for cataract and refractive surgery will broaden the company’s product portfolio and new product pipeline.

Since December 2011, the two companies have been co-promoting the VICTUS femtosecond laser platform, which performs both cataract and refractive procedures. The platform received marketing approval from regulatory authorities in Europe in late 2011 and received key clearances from the FDA in July 2012. Technolas Perfect Vision is also developing excimer lasers for advanced refractive procedures and in the EU is commercializing SUPRACOR, a new technology for the treatment of presbyopia.


Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

More in Ophthalmology